Home Valeant Pharma Q3 profit beats estimates, company raises outlook for Q4, 2015
 

Keywords :   


Valeant Pharma Q3 profit beats estimates, company raises outlook for Q4, 2015

2014-10-20 16:06:43| Biotech - Topix.net

Valeant Pharmaceuticals International Inc. beat analyst estimates for third-quarter profit and says both the fourth quarter and 2015 are looking more positive than estimates have forecast. The Montreal-area company reported US$275.4 million of net income, or 82 cents per share, under standard accounting and US$718.8 million after adjustments, resulting in $2.11 per share of adjusted EPS.

Tags: company profit estimates outlook

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.07Hurricane Beryl Update Statement
01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07BASFs TECH Academy Introduces Louisiana High School Students to Technical Careers
01.07Comericas Patterson Helps Entrepreneurs Grow Their Waste and Recycling Businesses
01.07Hitachi Zosen Inova Acquires Babcock & Wilcox's Denmark-Based Renewable Parts and Services Subsidiary
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Public Advisory Number 11A
01.07Summary for Hurricane Beryl (AT2/AL022024)
More »